NYSE:ALife Sciences
Agilent Technologies (A) Valuation Check As New Biopharma Collaborations And Logic Analyzers Expand Growth Story
Agilent Technologies (A) has been active on several fronts recently, from new collaborations in biopharma analytics to the launch of its 16850 Series portable logic analyzers, giving investors fresh context for assessing the stock.
See our latest analysis for Agilent Technologies.
Despite fresh product launches and new biopharma collaborations shaping sentiment, Agilent’s share price has eased recently. The 30-day share price return is down 4.05% and the year-to-date share price return is...